ATHI VENKATESH: Open Payments
NPI 1902952112 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 13 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $94 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $146 |
| Alkermes, Inc. | 1 | $129 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ABBVIE INC. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: UZEDY, LYBALVI, Auvelity, COBENFY, VRAYLAR, TRINTELLIX, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
